TherapeuticsMD Statistics
NASDAQ: TXMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.03+0.02 (+1.00%)
Market open · Delayed 15 min · as of Oct 9, 2:16 PM ET
TherapeuticsMD by the numbers
TherapeuticsMD has a market capitalization of $23.5 million based on 11.57M shares outstanding. With trailing EPS of $-0.04, TherapeuticsMD is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.6% below its 50-day average and 4.0% below its 200-day average.
Average daily trading volume is 23.49K shares, or about $47,683 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TXMD valuation vs. peer median
| Metric | TXMD | Peer median | Difference |
|---|---|---|---|
| Market cap | $23.50M | $22.55M | +4% |
| Avg. volume | 23.49K | 298.56K | -92% |
Peer median across 8 companies: OPTH, AYTU, QNRX, SHPH, BYSI, KYNB, COCP, UPC.
Valuation
- Market cap
- $23.50M
- Forward P/E
- 5.80
- EPS (TTM)
- $-0.04
- Shares outstanding
- 11.57M
Price and trading
- Previous close
- 2.01
- Open
- 2.00
- Day range
- 1.99 – 2.04
- 52-week range
- 1.03 – 2.95
- 52-week change
- +89.62%
- Beta
- —
- Volume
- 7.58K
- Average volume
- 23.49K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 23.50M
- Forward Pe
- 5.80
- Eps
- -0.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.95
- Week52 Low
- 1.03
- Avg Volume
- 23,489.00
- Shares Outstanding
- 11.57M
- Ma50
- 2.11
- Ma200
- 2.11
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -31.19%
- Pct From52w Low
- 97.09%